Pfizer said on Tuesday the next few years will be bumpy, beginning with 2026, due to lower sales of its COVID vaccine and ...

Tis the season for sniffling, coughing and calling out of work. Here's what to know about the pathogens circulating in the ...

Japan's upper house passed an 18.3 trillion yen ($118 billion) extra budget on Tuesday, giving Prime Minister Sanae Takaichi ...

The former chancellor says the government had a responsibility to support workers, but there was "always going to be a trade ...

The former chancellor Rishi Sunak has defended his pandemic-era Bounce Back Loan scheme against accusations that it was ...

It’s fall and time to consider receiving the newly updated COVID booster to better protect against the continually mutating ...

Northcutt's status was still pending when the Department of Defense ended the vaccine mandate. He served a total of 5.5 years ...

Secretary of Defense Pete Hegseth offered few details on his plan. But he said the military was alienating soldiers by ...

Today, Dec. 16, 2025, Pfizer's shrinking COVID cash flows could mean little growth next year as M&A bets will take time to ...

House Speaker Mike Johnson all but guaranteed that Congress will allow the enhanced premium tax credits to expire at the end ...

The latest federal jobs report reveals rising unemployment among Black workers, disappearing factory jobs and lopsided growth ...

Pfizer on ​Tuesday ‌forecast 2026 profit ‌below Wall Street estimates, sending its ⁠shares ‌down 1. The ‍drugmaker expects ...